The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
9.89
+0.08 (0.87%)
Apr 23, 2025, 4:00 PM EDT - Market closed
The Joint Market Cap
The Joint has a market cap or net worth of $151.46 million as of April 23, 2025. Its market cap has decreased by -19.52% in one year.
Market Cap
151.46M
Enterprise Value
131.53M
1-Year Change
-19.52%
Ranking
Category
Stock Price
$9.89
Market Cap Chart
Since November 11, 2014, The Joint's market cap has increased from $60.30M to $151.46M, an increase of 151.18%. That is a compound annual growth rate of 9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 148.70M | -6.65% |
| Dec 31, 2024 | 159.30M | 12.34% |
| Dec 29, 2023 | 141.80M | -30.18% |
| Dec 30, 2022 | 203.10M | -78.55% |
| Dec 31, 2021 | 946.80M | 156.79% |
| Dec 31, 2020 | 368.70M | 64.75% |
| Dec 31, 2019 | 223.80M | 95.80% |
| Dec 31, 2018 | 114.30M | 70.34% |
| Dec 29, 2017 | 67.10M | 99.11% |
| Dec 30, 2016 | 33.70M | -42.98% |
| Dec 31, 2015 | 59.10M | -4.68% |
| Dec 31, 2014 | 62.00M | 2.82% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.99B |
| UnitedHealth Group | 390.80B |
| Johnson & Johnson | 381.29B |
| AbbVie | 305.15B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 228.01B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |